LBA24 KRYSTAL-1: Updated efficacy and safety of adagrasib (MRTX849) with or without cetuximab in patients with advanced colorectal cancer (CRC) harboring a KRASG12C mutation

S.J. Klempner, J. Weiss, M. Pelster, A. Spira, M. Barve, S-H.I. Ou, T.A. Leal, T. Bekaii-Saab, J.G. Christensen, T. Kheoh, K. Velastegui, H. Der Torossian, R. Yaeger